CTXR icon

Citius Pharmaceuticals
CTXR

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$6
314% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
D. Boral Capital
D. Boral Capital
Jason Kolbert
44% 1-yr CTXR win rate
13 Aug ‘25 2 months ago